In the rapidly growing field of synthetic biology, in which organisms can be engineered to do things like decompose plastic and manufacture biofuels and medicines, production of custom DNA sequences is a fundamental tool for scientific discovery. Yet the process of DNA synthesis, which has remained virtually unchanged for more than 40 years, can be slow and unreliable.
Now in what could address a critical bottleneck in biology research, researchers at the Department of Energy’s Joint BioEnergy Institute (JBEI), based at Lawrence Berkeley National Laboratory (Berkeley Lab), announced they have pioneered a new way to synthesize DNA sequences through a creative use of enzymes that promises to be faster, cheaper, and more accurate. The discovery, led by JBEI graduate students Sebastian Palluk and Daniel Arlow, was published in Nature Biotechnology in a paper titled “De novo DNA Synthesis Using Polymerase-Nucleotide Conjugates.”
“DNA synthesis is at the core of everything we try to do when we build biology,” said JBEI CEO Jay Keasling, the corresponding author on the paper and also a Berkeley Lab senior faculty scientist. “Sebastian and Dan have created what I think will be the best way to synthesize DNA since [Marvin] Caruthers invented solid-phase DNA synthesis almost 40 years ago. What this means for science is that we can engineer biology much less expensively – and in new ways – than we would have been able to do in the past.”
The Caruthers process uses the tools of organic chemistry to attach DNA building blocks one at a time and has become the standard method used by DNA synthesis companies and labs around the world. However, it has drawbacks, the main ones being that it reaches its limit at about 200 bases, partly due to side reactions than can occur during the synthesis procedure, and that it produces hazardous waste. For researchers, even 1,000 bases is considered a small gene, so to make longer sequences, the shorter ones are stitched together using a process that is failure-prone and can’t make certain sequences.
Buying your genes online
A DNA sequence is made up of a combination of four chemical bases, represented by the letters A, C, T, and G. Researchers regularly work with genes of several thousand bases in length. To obtain them, they either need to isolate the genes from an existing organism, or they can order the genes from a company.
“You literally paste the sequence into a website, then wait two weeks,” Arlow said. “Let’s say you buy 10 genes. Maybe nine of them will be delivered to you on time. In addition, if you want to test a thousand genes, at $300 per gene, the costs add up very quickly.”
Palluk and Arlow were motivated to work on this problem because, as students, they were spending many long, tedious hours making DNA sequences for their experiments when they would much rather have been doing the actual experiment.
“DNA is a huge biomolecule,” Palluk said. “Nature makes biomolecules using enzymes, and those enzymes are amazingly good at handling DNA and copying DNA. Typically our organic chemistry processes are not anywhere close to the precision that natural enzymes offer.”
Thinking outside the box
The idea of using an enzyme to make DNA is not new – scientists have been trying for decades to find a way to do it, without success. The enzyme of choice is called TdT (terminal deoxynucleotidyl transferase), which is found in the immune system of vertebrates and is one of the few enzymes in nature that writes new DNA from scratch rather than copying DNA. What’s more, it’s fast, able to add 200 bases per minute.
In order to harness TdT to synthesize a desired sequence, the key requirement is to make it add just one nucleotide, or DNA building block, and then stop before it keeps adding the same nucleotide repeatedly. All of the previous proposals envisioned using nucleotides modified with special blocking groups to prevent multiple additions. However, the problem is that the catalytic site of the enzyme is not large enough to accept the nucleotide with a blocking group attached. “People have basically tried to ‘dig a hole’ in the enzyme by mutating it to make room for this blocking group,” Arlow said. “It’s tricky because you need to make space for it but also not screw up the activity of the enzyme.”
Palluk and Arlow came up with a different approach. “Instead of trying to dig a hole in the enzyme, what we do is tether one nucleotide to each TdT enzyme via a cleavable linker,” Arlow said. “That way, after extending a DNA molecule using its tethered nucleotide, the enzyme has no other nucleotides available to add, so it stops. A key advantage of this approach is that the backbone of the DNA – the part that actually does the chemical reaction – is just like natural DNA, so we can try to get the full speed out of the enzyme.”
Once the nucleotide is added to the DNA molecule, the enzyme is cleaved off. Then the cycle can begin again with the next nucleotide tethered to another TdT enzyme.
Keasling finds the approach clever and counterintuitive. “Rather than reusing an enzyme as a catalyst, they said, ‘Hey, we can make enzymes really inexpensively. Let’s just throw it away.’ So the enzyme becomes a reagent rather than a catalyst,” he said. “That kind of thinking then allowed them to do something very different from what’s been proposed in the literature and – I think – accomplish something really important.”
They demonstrated their method by manually making a DNA sequence of 10 bases. Not surprisingly, the two students were initially met with skepticism. “Even when we had first results, people would say, ‘It doesn’t make sense; it doesn’t seem right. That’s not how you use an enzyme,’” Palluk recalled.
The two still have much work to do to optimize their method, but they are reasonably confident that they will be able to eventually make a gene with 1,000 bases in one go at many times the speed of the chemical method.
Berkeley Lab has world-renowned capabilities in synthetic biology, technology development for biology, and engineering for biological process development. A number of technologies developed at JBEI and by the Lab’s Biosciences Area researchers have been spun into startups, including Lygos, Afingen, TeselaGen, and CinderBio.
“After decades of optimization and fine-tuning, the conventional method now typically achieves a yield of about 99.5 percent per step. Our proof-of-concept synthesis had a yield of 98 percent per step, so it’s not quite on par yet, but it’s a promising starting point,” Palluk said. “We think that we’ll catch up soon and believe that we can push the system far beyond the current limitations of chemical synthesis.”
“Our dream is to make a gene overnight,” Arlow said. “For companies trying to sustainably biomanufacture useful products, new pharmaceuticals, or tools for more environmentally friendly agriculture, and for JBEI and DOE, where we’re trying to produce fuels and chemicals from biomass, DNA synthesis is a key step. If you speed that up, it could drastically accelerate the whole process of discovery.”
The Latest on: DNA synthesis
via Google News
The Latest on: DNA synthesis
- Evonetix, imec Partner on Chip-Based Technology Scale-Upon January 31, 2020 at 8:48 am
Evonetix’s technology is based on a silicon chip, made by MEMS processing, that controls the synthesis of DNA at many thousands of independently controlled reaction sites or ‘pixels’ on the chip ...
- Increased brain growth, mutations and autism linked in new studyon January 30, 2020 at 11:47 am
the cell senses a replication-linked danger to the integrity of the genome which is slowing or even stalling the process of DNA synthesis and replication fork progression. This is called replication ...
- The Role of Co-Chaperones Involved in Ribonucleotide Reductase (RNR) Activityon January 28, 2020 at 12:46 am
RNR is an enzyme that converts ribonucleotides (NTPs) to deoxyribonucleotides (dNTPs). This conversion is essential for DNA synthesis making RNR an attractive target for anti-cancer therapies, as ...
- Twist Bioscience Announces Completion of $50 Million Registered Direct Offering Priced At-The-Marketon January 27, 2020 at 3:02 pm
About Twist Bioscience Corporation Twist Bioscience is a leading and rapidly growing synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering ...
- Synthetic DNA Being Developed to Store Excess Intelligence Dataon January 27, 2020 at 8:00 am
DNA, to store digital data,” said Emily Leproust, CEO of Twist Bioscience, a company working alongside Georgia Tech on the MIST program. “We can truly revolutionize the DNA synthesis process, and ...
- Microsoft and Univ. of Washington join Georgia Tech team in $25M DNA data storage projecton January 25, 2020 at 4:21 am
Twist Bioscience, a longtime partner in UW’s research, will engineer the DNA synthesis platform on silicon that will “write” the DNA strands carrying the data. Roswell Biotechnologies will develop the ...
- DNA-Based Storage Nears Scalable Reality with New $25 Million Projecton January 22, 2020 at 4:09 am
Their joint project – called Scalable Molecular Archival Software and Hardware, or “SMASH” – will aim to engineer a silicon-based DNA synthesis platform that can write data-loaded DNA strands and ...
- ImmunoPrecise integrates SGI-DNA's benchtop automated DNA printer to accelerate antibody discovery and manufacturing serviceson January 20, 2020 at 7:25 pm
ImmunoPrecise integrates SGI-DNA's benchtop automated DNA printer to accelerate antibody discovery and manufacturing services ...
- ImmunoPrecise Antibodies bolsters its capability at European operations with automated DNA printeron January 20, 2020 at 9:20 am
Dr Martin Hessing, general manager of Immunoprecise's Dutch subsidiary U-Protein Express, added: "By automating rapid DNA synthesis, we will put IPA in a competitive position, allowing faster delivery ...
via Bing News